Sorin Fedeles

Sorin Fedeles, PhD, MBA, serves as the Executive Director of the Polycystic Kidney Disease Outcomes Consortium at the Critical Path Institute since October 2021, where responsibilities include strategic oversight and collaborative research management. Simultaneously, in June 2016, Sorin became an Assistant Professor of Medicine in Nephrology at Yale University School of Medicine, leading a research program focused on polycystic kidney and liver diseases. With over 15 years of experience in these fields, Sorin has held various roles including co-founder and Director of Business Development at TargetSite Therapeutics and Entrepreneur in Residence at Yale Office of Cooperative Research. Sorin's educational background includes a Ph.D. in Genetics and an MBA with an Executive Track in Leadership in Healthcare from Yale University, complemented by postdoctoral training in medicine and additional degrees in biological sciences and biochemistry/cell biology.